Procurement

NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

NHS England

Procurement identifier (OCID): ocds-h6vhtk-051a9d

Description

NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731

Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Notices

UK4: Tender notice

Notice identifier: 2026/S 000-016135
Published: 23 February 2026, 2:41pm

UK2: Preliminary market engagement notice

Notice identifier: 2026/S 000-014706
Published: 18 February 2026, 12:08pm

Show all versions

UK1: Pipeline notice

Notice identifier: 2025/S 000-029487
Published: 3 June 2025, 12:58pm